The Impact of COVID-19 on Lombardy Region ST-Elevation Myocardial Infarction Emergency Medical System Network-A

Giuseppe Stirparo1,2, Lorenzo Bellini1, Giuseppe Ristagno3,4

  • 1Faculty of Medicine, School of Public Health, University of Vita-Salute San Raffaele, Via Olgettina 60, 20090 Milano, Italy.

Insights

The COVID-19 pandemic increased emergency medical system response times for ST-elevation myocardial infarction (STEMI) patients. However, pre-hospital treatment protocols, like fibrinolysis, remained unchanged during this period.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted emergency medical systems globally.
  • Limited data exists on the pandemic's impact on ST-elevation myocardial infarction (STEMI) time-sensitive networks.
  • Understanding these impacts is crucial for optimizing pre-hospital STEMI management, including fibrinolysis protocols.

Purpose of the Study:

  • To investigate the effects of the COVID-19 pandemic on emergency medical system response times for STEMI patients.
  • To assess changes in STEMI diagnosis rates and hospital access during the pandemic.
  • To evaluate the adherence to pre-hospital clinical protocols during the pandemic.

Main Methods:

  • Retrospective observational cohort study.
  • Analysis of STEMI rescues from the Lombardy EMS registry (January 2019 - December 2021).
  • Comparison of pre-pandemic, first wave, and later pandemic periods.

Main Results:

  • A reduction in STEMI diagnoses was observed in March 2020 compared to March 2019 (OR 0.76).
  • Average emergency medical mission times increased from 57.7 min in 2019 to 64.7 min in 2020 and 63.1 min in 2021.
  • The number of specialized STEMI treatment centers (HUBs) decreased significantly from 52 pre-pandemic to 13 during the first wave.

Conclusions:

  • The COVID-19 pandemic led to increased transportation times for STEMI patients.
  • Despite longer transport times, the out-of-hospital clinical management approach for STEMI did not change.
  • Fibrinolysis was not implemented in the out-of-hospital setting during the study period, irrespective of pandemic-related changes.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
57
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
40
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
22